Friday 6 November 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.

Revenue: +9.96%
EPS: +267.0%
Free cash flow: −50.9%
Total debt: +23.8%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

19.90 0.45 +2.31%

Follow AMRX

Alert me

Market cap: $6.8B
P/E: 36.9×
Fwd P/E: 44.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

AMNEAL PHARMACEUTICALS, INC. (AMRX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, AMNEAL PHARMACEUTICALS, INC. (AMRX) trades at a P/B ratio of 59.5×. Over the past ten years it has ranged from 0.0× (June 2026) to 198× (September 2026); the current reading is higher than 96% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 1.8× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AMRX/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AMNEAL PHARMACEUTICALS, INC. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AMRX/metrics/pb-ratio">AMNEAL PHARMACEUTICALS, INC. (AMRX) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	52.6×	2,940.59%
FY2022	1.7×	(10.94%)
FY2021	1.9×	(0.50%)
FY2020	2.0×	6.39%
FY2019	1.8×	(4.41%)
FY2018	1.9×	(89.35%)
FY2017	18.0×	0.00%
FY2016	18.0×	0.00%

Period	P/B ratio	Change
Sep 2026	61.8×	(63.08%)
Jun 2026	167×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 198×

Ten-year median 1.8×

Current reading's percentile 95

Company	P/B ratio
SUPN Indivior Pharmaceuticals Inc. compare	n/m
ELAN Elanco Animal Health Incorporated compare	1.8×
RDY Dr. Reddy's Laboratories Ltd compare	3.0×
ALKS Alkermes plc compare	4.0×
LNTH Lantheus Holdings, Inc. compare	4.9×
KNSA Kiniksa Pharmaceuticals International, plc compare	9.7×
HIMS Hims & Hers Health, Inc. compare	17.2×
LQDA Liquidia Corporation compare	20.4×
AMRX AMNEAL PHARMACEUTICALS, INC.	59.5×
Drug Manufacturers Specialty & Generic industry median	1.8×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

AMNEAL PHARMACEUTICALS, INC. (AMRX) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on AMRX

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on AMRX

Stockrow Weekly